Elekta (OTCMKTS:EKTAY) Sees Strong Trading Volume – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) shares saw unusually-strong trading volume on Tuesday . Approximately 8,635 shares changed hands during mid-day trading, an increase of 250% from the previous session’s volume of 2,464 shares.The stock last traded at $5.0410 and had previously closed at $5.00.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, According to data from MarketBeat, Elekta currently has an average rating of “Sell”.

Elekta Price Performance

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The firm has a market capitalization of $1.86 billion, a PE ratio of -31.51 and a beta of 1.00. The company has a 50-day moving average price of $5.76 and a 200-day moving average price of $6.02.

Elekta (OTCMKTS:EKTAY) last announced its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The firm had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. Sell-side analysts forecast that Elekta AB will post 0.43 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.